Diagnosis and treatment mistakes in acute forms of ischaemic heart disease
Authors:
M. Gřiva 1; R. Náplava 1; O. Hlinomaz 2
Authors place of work:
Interní klinika IPVZ, Krajská nemocnice T. Bati a. s., Zlín
1; I. interní kardioangiologická klinika FN u sv. Anny, Brno
2
Published in the journal:
Kardiol Rev Int Med 2009, 11(2): 48-53
Summary
Not only cardiologists but also other specialists are faced with diagnoses and differential diagnoses of acute coronary syndrome. The paper provides an overview, in chronological order, of some difficulties and mistakes in history taking, clinical examinations and the conduct of standard investigations as part of the diagnostic process. Furthermore, the paper outlines possible treatment shortfalls and errors. Rapid diagnosis and correct treatment are the main prerequisites for preventing serious complications or even death in acute coronary syndrome.
Keywords:
akutní koronární syndrom – STEMI – non-STEMI – diagnostika – léčba
Zdroje
1. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525–2538.
2. Werf FV, Bax J, Betriu A et al. The Task Force on the management of ST‑segment elevation acute myocardial infarction of the European Society of Cardiology: Management of acute myocardial infarction in patients presenting with persistent ST‑segment elevation. Eur Heart J 2008; 29: 2909–2945.
3. Meine TJ, Al-Khatib SM, Alexander JH et al. Incidence, predictors, and outcomes of high‑degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J 2005; 149: 670–674.
4. Bělohlávek J, Aschermann M. Doporučený postup pro diagnostiku a léčbu akutních koronárních syndromů bez elevací ST úseků na EKG. Cor Vasa 2008; 50: 1S7–1S23.
5. Bassand JP, Hamm CV, Ardissino D et al. Guidelines for the diagnosis and treatment of non‑ST‑segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598–1660.
6. Cheitlin MD, Armstrong WF, Aurigemma GP et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force of Practise Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108: 1146–1162.
7. Veselka J. Hledá se kardiolog. Zn.: Znalost CT a MR srdce nutná! Cor Vasa 2007; 49: 346–347.
8. Schomig A, Mehilli J, Antoniucci D et al. Betone 12 h Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005; 293: 2865–2872.
9. Hochman JS, Lamas GA, Bulle CE et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355: 2395–2407.
10. Menon V, Pearte CA, Buller CE et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. Eur Heart J 2009; 30: 183–191.
11. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST‑segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367: 569–578.
12. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST‑elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006; 367: 579–588.
13. Ellis SG, Tendera M, de Belder MA et al. FINESSE Investigators. Facilitated PCI in patients with ST‑elevation myocardial infarction. N Engl J Med 2008; 358: 2205–2217.
14. Van’t Hof AW, Ten Berg J, Heestermans T et al. Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST‑elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet 2008; 372: 537–546.
15. Yusuf S, Mehta SR, Chrolavicius S et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST‑segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA 2006; 295: 1519–1530.
16. Yusuf S, Zhao F, Mehta SR et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST‑segment elevation. N Engl J Med 2001; 345: 494–502.
17. Yusuf S, Mehta SR, Chrolavicius S et al. Efficacy and safety of fondaparinux compared to enoxaparin in 20,078 patients with acute coronary syndromes without ST segment elevation. The OASIS (Organization to Assess Strategie in Acute Ischemic Syndromes)-5 Investigators. N Engl J Med 2006; 354: 1464–1476.
18. Kala P, Poloczek M. Patofyziologie akutního infarktu myokardu bez elevací úseku ST a specifika léčby v České republice. Cor Vasa 2008; 50: 413–417.
19. Antman EM, Cohen M, Bernink PJ et al. The TIMI risk score for unstable angina/non‑ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–842.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2009 Číslo 2
Najčítanejšie v tomto čísle
- Diagnosis and treatment mistakes in acute forms of ischaemic heart disease
- Immunosuppression treatment following heart transplantation
- Cardiometabolic risk is a threat for the 21st century cardiology
- Rehabilitation of patients with ischemic heart disease